Advocacy Tools
Advocacy materials and tools developed by hepCoalition and partner organizations that can be adapted and used by advocates for local campaigns in their own contexts. Includes training materials, community monitoring/data collection, and graphics.
Materials in this section
Eliminating Hepatitis C in Europe: Report on Policy Implementation for People Who Inject Drugs
C-EHRN releases a report focusing on the availability of and access to interventions that constitute the HCV continuum of care specific for people who inject drugs in 40 European cities in 2024. More
Gender-Transformative Harm Reduction Services
C-EHRN releases a report aiming to inform the development of gender-transformative harm reduction practices in Europe. More
The Potential Impact of the Comprehensive and Progressive Agreement for Trans-Pacific Partnership on Thailand’s Hepatitis C Treatment Program
Acceding to trade agreements such as the CPTPP that require increasing intellectual property protection, could compromise Thailand’s hepatitis C program and other national treatment programs reliant on affordable generic medicines. More
Essential Harm Reduction Services in Europe: Report on Policy Implementation for People Who Use Drugs
C-EHRN releases a report assessing the state of essential harm reduction services in 40 European cities in 2024. More
Global State of Harm Reduction 2024
Harm Reduction International releases the 9th edition of the Global State of Harm Reduction report, providing an independent analysis of harm reduction in the world. More
INHSU Prisons Hepatitis C Advocacy Toolkit
The toolkit provides guidance across three core areas with the aim of supporting advocacy efforts for the scale-up or implementation of prison-based hepatitis C testing, treatment and prevention services. More
Hidden Costs: GeneXpert Tests and Danaher’s Delayed Audit
A technical brief makes recommendations to Danaher, as well as global health actors and governments, to ensure the audit is conducted in a timely, rigorous and transparent manner. More
Creating Safer Consumption Spaces in Europe: Evolving Contexts and Implications for Policy
C-EHRN releases a policy brief providing an overview of the state of the art regarding Drug Consumption Rooms, as well as an overview of recommendations and examples of good practices for policymakers. More
The Cost of Complacency: A Harm Reduction Funding Crisis
Harm Reduction International releases its annual report exploring the state of harm reduction funding in low- and middle-income countries. More
HIV and Viral Hepatitis Diagnostic Tests in LMICs: Forecasts of Global and Regional Demand for 2022-2026
WHO releases a report jointly presenting diagnostic test forecasts across disease areas in recognition of the benefits of addressing HIV and viral hepatitis B and C in a coordinated manner. More
